Targeted agents for cancer treatment during pregnancy

Cancer Treatment Reviews
Matteo LambertiniHatem A Azim

Abstract

The last decade has witnessed important advances in the field of managing cancer during pregnancy. However, still limited data is available on the safety of administering targeted agents in pregnant cancer patients. Given the increasing use of targeted agents in clinical practice, it is becoming vital to properly understand how far they can be used in a pregnant patient without compromising the outcome of the fetus. Unlike chemotherapy, monoclonal antibodies are large molecules that require active transport via the placenta to reach the fetus. On the other hand, similarly to chemotherapy, small molecules like tyrosine kinase inhibitors (TKIs) can cross the placenta throughout the pregnancy period. The majority of targeted agents have worrying preclinical data discouraging their use during pregnancy. Multi-TKIs are of particular concern given their potential interference with other vital physiological functions that could be necessary in fetal development. Yet this does not mean that all targeted agents should be avoided completely during pregnancy. The current review provides a critical evaluation on all targeted agents that are currently in clinical use and provides a guide in order to help clinicians counseling their pregnant...Continue Reading

References

Jan 1, 1995·Fetal Diagnosis and Therapy·J C PonsJ F Delfraissy
Oct 1, 1994·The Journal of Pediatric Endocrinology·D Evain-Brion, E Alsat
Oct 1, 1993·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·P R GoodyerC Goodyer
Aug 1, 1997·Kidney International·N KeeA V Cybulsky
Jul 30, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·B L SiuA L Fenrich
Feb 3, 2005·DNA and Cell Biology·Jing NiSidong Xiong
Jul 30, 2005·Molecular Endocrinology·Marco ContiYou-Qiang Su
Dec 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·George Pentheroudakis, Nicholas Pavlidis
Nov 10, 2006·Clinical Breast Cancer·Hanna KellyE Claire Dees
Mar 23, 2007·Journal of Perinatology : Official Journal of the California Perinatal Association·M A RussellM J Egorin
Jun 19, 2007·Acta histochemica·Ramazan DemirBerthold Huppertz
Dec 8, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Alberto ZambelliLorenzo Pavesi
Mar 7, 2008·Blood·Seonaid M PyeJane F Apperley
May 22, 2008·Reproductive Biomedicine Online·Cammi GoodmanC B Coulam
Aug 21, 2008·Breast Cancer Research and Treatment·Fedro A PeccatoriAron Goldhirsch
Sep 13, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kan HeLisa J Christopher
Dec 17, 2008·Archives of Gynecology and Obstetrics·Ridvan AliAhmet Tunali
Jul 25, 2009·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Nele Pentsuk, Jan Willem van der Laan
Nov 10, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hatem A AzimNicholas Pavlidis
Sep 25, 2010·Birth Defects Research. Part A, Clinical and Molecular Teratology·Jane Adams
Oct 7, 2010·Retina·Ryan M TarantolaVinit B Mahajan
Oct 12, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Frédéric AmantAndreas Du Bois
Nov 26, 2010·Blood·Eliza F ChakravartyPamela Farmer
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jul 26, 2011·The Breast : Official Journal of the European Society of Mastology·Antonis ValachisVassilios Georgoulias
Sep 17, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Chee-Hong LeeNai-Lang Lai
Mar 1, 2012·Breast Cancer Research and Treatment·Hatem A AzimMartine Piccart-Gebhart
Mar 17, 2012·Anti-cancer Drugs·Paul BerveillerVassilis Tsatsaris

❮ Previous
Next ❯

Citations

Jan 1, 2016·Nature Reviews. Clinical Oncology·Helen Gharwan, Hunter Groninger
Jun 30, 2015·Expert Opinion on Drug Safety·Matteo LambertiniHatem A Azim
Mar 10, 2016·Neurotoxicology·Dorothée C-M VercruysseFrederic Amant
Jun 10, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·G ZarkavelisN Pavlidis
Nov 7, 2015·Best Practice & Research. Clinical Obstetrics & Gynaecology·Catherine M Albright, Katharine D Wenstrom
Aug 12, 2016·BMC Cancer·Agnes StefansdottirNorah Spears
Nov 9, 2016·Critical Reviews in Oncology/hematology·Elena LorenziArmando Santoro
Feb 17, 2017·Journal of Adolescent and Young Adult Oncology·Angela DautiAntoinette Anazodo
Apr 4, 2017·Toxicological Sciences : an Official Journal of the Society of Toxicology·Gaby A M EliesenRick Greupink
Feb 25, 2017·The Oncologist·Shlomit Strulov ShacharCarey K Anders
Jun 15, 2017·Current Opinion in Oncology·Ingrid BoereFrédéric Amant
Oct 18, 2019·Japan Journal of Nursing Science : JJNS·Mika KozuTomoko Majima
Feb 21, 2019·Oncotarget·Matteo Lambertini, Giulia Viglietti
Jul 31, 2020·Tumori·Julia BerwartEmilia Pressel Coretto
Jan 7, 2017·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·L A Schneider
May 1, 2016·European Journal of Hospital Pharmacy. Science and Practice·D SalatA Vallano
May 6, 2019·Expert Review of Hematology·Anna Gurevich-Shapiro, Irit Avivi
Sep 11, 2020·JCO Oncology Practice·Jordyn SilversteinKatherine Van Loon
Jan 20, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Charlotte MaggenFrédéric Amant
Oct 22, 2020·Archives of Toxicology·Gaby A M EliesenRick Greupink
Nov 17, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A CubilloÁ Rodríguez-Lescure
Dec 9, 2020·Cancers·Francesca PoggioMatteo Lambertini
Mar 3, 2021·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Vera WoltersFrédéric Amant
Nov 19, 2020·Urology·Charlotte MaggenUNKNOWN International Network on Cancer, Infertility and Pregnancy (INCIP).
May 4, 2021·Radiology and Oncology·Erika Matos, Tanja Ovcaricek
Jun 17, 2021·Breast Cancer Research and Treatment·Wendy R Muñoz-MontañoCynthia Villarreal-Garza
Jul 3, 2021·Cancers·Roxana SchwabAnnette Hasenburg

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
Mircea DediuCristian Gal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Lecia V SequistDaniel A Haber
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Guus A M S van DongenDanielle J Vugts
Experimental Hematology & Oncology
Fei-Yu Niu, Yi-Long Wu
© 2021 Meta ULC. All rights reserved